ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 135 filers reported holding ASCENDIS PHARMA A/S in Q2 2019. The put-call ratio across all filers is 0.27 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,975,827 | +4.9% | 170,609 | 0.0% | 1.19% | +14.6% |
| Q2 2023 | $15,226,853 | -43.5% | 170,609 | -32.1% | 1.04% | -49.2% |
| Q1 2023 | $26,953,714 | +33.0% | 251,387 | +51.5% | 2.05% | +15.4% |
| Q4 2022 | $20,265,886 | +42.7% | 165,937 | +20.6% | 1.78% | +34.9% |
| Q3 2022 | $14,204,000 | +42.9% | 137,554 | +28.6% | 1.32% | +40.3% |
| Q2 2022 | $9,940,000 | -54.8% | 106,931 | -42.9% | 0.94% | -40.0% |
| Q1 2022 | $21,993,000 | +45.8% | 187,401 | +67.1% | 1.56% | +63.9% |
| Q4 2021 | $15,084,000 | +248.8% | 112,122 | +313.2% | 0.96% | +202.2% |
| Q3 2021 | $4,325,000 | +692.1% | 27,134 | +484.4% | 0.32% | +544.9% |
| Q1 2019 | $546,000 | – | 4,643 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |